Eric Lim

Eric Lim: Immunotherapy – before, after or both?

Eric Lim, Professor of Thoracic Surgery at Royal Brompton Hospital, shared his recent article on X:

“Immunotherapy – before, after or both?

Meta-analysis from published trial results to date suggests overall survival is best with a neo-adjuvant approach, and it would save a lot of time, effort and money too!”

Impact of the timing of immunotherapy administration on overall survival for resectable non-small cell lung cancer (iACORN study): A systematic review and meta-analysis of randomised trials.

Authors: Akshay J. Patel, et al.

 Eric Lim: Immunotherapy - before, after or both?

Akshay J. Patel cancer Eric Lim immunotherapy non small cell lung cancer NSCLC OncoDaily Oncology Royal Brompton Hospital Thoracic Surgery